PASW (Ping An Biomedical Co) Marketable Securities: $0.00 Mil (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PASW Ping An Biomedical Co Ltd PASW
17 GF Score
Price $0.12
! 3 Warning Signs
View Full Analysis

What is Ping An Biomedical Co Marketable Securities?

Ping An Biomedical Co PASW -6.49% 17 Marketable Securities is $0.00 Mil as of Sep. 2025. GuruFocus rates PASW with a GF Score™ of 17/100. The stock has 3 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Ping An Biomedical Co's Marketable Securities for the quarter that ended in Sep. 2025 was $0.00 Mil.

Ping An Biomedical Co  (NAS:PASW) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Ping An Biomedical Co Marketable Securities Related Terms

Ping An Biomedical Co Marketable Securities Historical Data

* Premium members only.

The historical data trend for Ping An Biomedical Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ping An Biomedical Co Marketable Securities Chart

Ping An Biomedical Co Annual Data
Trend Sep21 Sep22 Sep23 Sep24 Sep25
Marketable Securities
0.00 0.00 0.00 0.00 0.00

Ping An Biomedical Co Semi-Annual Data
Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Marketable Securities Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00
PASW
17GF Score
Ping An Biomedical Co Ltd PASW
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ping An Biomedical Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $0.00 Mil mean?
Ping An Biomedical Co (PASW) has a Marketable Securities of $0.00 Mil as of Sep. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Ping An Biomedical Co and its competitors.
Is Ping An Biomedical Co's Marketable Securities too high?
Ping An Biomedical Co's current Marketable Securities is $0.00 Mil. Overall, Ping An Biomedical Co has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Ping An Biomedical Co's Marketable Securities compare to DXYN and CULP?
Ping An Biomedical Co's Marketable Securities of $0.00 Mil can be compared against companies in the Manufacturing - Apparel & Accessories industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Manufacturing - Apparel & Accessories company?
A good Marketable Securities depends on the Manufacturing - Apparel & Accessories industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Ping An Biomedical Co and its competitors. Ping An Biomedical Co's current Marketable Securities is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ping An Biomedical Co stock overvalued right now?
Ping An Biomedical Co (PASW) has a current Marketable Securities of $0.00 Mil. The current Marketable Securities is $0.00 Mil. Ping An Biomedical Co's overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Ping An Biomedical Co (PASW), the current Marketable Securities is $0.00 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ping An Biomedical Co Business Description

Address Tai Nan West Street, 1002-1008, 22nd Floor, China United Plaza, Cheung Sha Wan, Kowloon, Hong Kong, HKG
Ping An Biomedical Co Ltd formerly Majestic Ideal Holdings Ltd is a Cayman Islands-based holding company, conducting operations through its PRC subsidiary, NewBrand. The group is a provider of SCM services in the apparel industry, offering solutions for a broad range of yarn products, textiles, and finished garments. Its service offerings encompass every key aspect of the supply chain of textile products, such as market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The group has two reportable segments, yarns and finished garments. The majority of its revenue is generated from the sale of yarns, including pure cashmere and cashmere-mix yarn, merino wool, cotton, and fancy yarn.
17GF Score

Get the complete analysis for PASW

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.12
Price